TLX News - Candlesense

Telix to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference and H.C. Wainwright 27th Annual Global Investment Conference

MELBOURNE, Australia and INDIANAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will present at the Morgan Stanley 23rd Annual Global Healt...

Investor relations

8 days ago

TLX Investors Have Opportunity to Join Telix Pharmaceuticals Limited Fraud Investigation with the Schall Law Firm

LOS ANGELES, Aug. 25, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Telix Pharmaceutic...

What is the expected timeline for the investigation and any related regulatory actions? How might the investigation affect TLX's short‑term liquidity and ability to raise capital? What potential financial exposure could Telix face if the fraud allegations are substantiated?

Lawsuits

9 days ago

Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation – TLX

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Telix Pharmaceuticals Ltd. ...

What potential financial exposure could Telix face if the allegations are proven true? What is the expected timeline for the investigation and potential settlement, if any? How likely is the securities class action investigation to affect Telix's short‑term stock price?

Legal

13 days ago

Telix Pharmaceuticals Limited Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – TLX

LOS ANGELES--(BUSINESS WIRE)--Telix Pharmaceuticals Limited Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – TLX

How might this news influence investor sentiment and the company's valuation relative to its sector peers? What potential penalties or legal outcomes could arise from the securities fraud allegations? How will the investigation affect Telix Pharmaceuticals' short-term stock volatility?

Legal

13 days ago

TLX Investors Have Opportunity to Join Telix Pharmaceuticals Limited Fraud Investigation with the Schall Law Firm

LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Telix Pharmaceutic...

What are the potential financial and operational ramifications for Telix if the investigation confirms securities‑law violations, and how could this impact its competitive standing and long‑term valuation? What is the expected timeline for the investigation and potential resolution, and how might that timeline influence market positioning? How will the fraud investigation affect TLX's short‑term stock volatility and price direction?

Lawsuits

13 days ago

Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth

MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year end...

How will the half‑year results impact Telix's valuation multiples relative to peers in the pharma sector and affect short‑term trading activity? What are the details of the announced investments for long‑term growth—capital allocation, R&D pipeline milestones, and potential dilution or financing needs? How does the reported revenue and earnings growth compare to Telix's guidance and analyst expectations for H1 2025?

Earnings

14 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX

NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX). Such investors are ad...

How might this affect the sentiment of institutional investors and analyst coverage of Telix? What are the potential implications for Telix's ongoing clinical trials and product pipeline? Are there any insider trading activities or unusual volume patterns surrounding the announcement?

Lawsuits

23 days ago